Physician profile

Michael Rosenblatt

Endocrinology, Diabetes & Metabolism · Boston, MA

NPI 1699896753

$446,541.16

in general payments reported to CMS, 2019-2025

9 companies · $156 in 2025

The $156 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).

See the full distribution for Endocrinology, Diabetes & Metabolism

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$90,000.00
Travel and Lodging$200.00
Food and Beverage$156.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Ferring Holding INC. $364,151.57 2019-2023
Ferring Pharmaceuticals INC. $62,479.00 2019-2025
Radius Health, INC. $8,412.46 2020-2022
Genentech, INC. $6,371.07 2019
Helsinn Healthcare Sa $3,750.00 2021
Vertex Pharmaceuticals Incorporated $1,160.00 2022
Ferring International Center Sa $130.73 2022
Johnson & Johnson Vision Care, INC. $69.62 2020-2021
Medtronic USA, INC. $16.71 2019

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Michael Rosenblatt

$446,541.16

in general payments reported 2019-2025

Years
2019-2025
Top company
Ferring Holding INC.
Context
The $156 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).

https://glasscript.com/doctor/725240/michael-rosenblatt

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.